Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.
- Published In:
- Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 33(5), 478-490 (2024)
- Authors:
- Al-Sabah, Salman, Al-Khairi, Irina, Jamal, Mohammad, Qaddoumi, Mohammad, Alajmi, Fahad, Kumar, Jijin, Abukhalaf, Nermeen, Cherian, Preethi, Madhu, Dhanya, Arefanian, Hossein, Dsouza, Carol, Alam-Eldin, Nada, AlSabagh, Abdullah, Al Madhoun, Ashraf, Al-Sabah, Suleiman, Al-Mulla, Fahd, Abu-Farha, Mohamed, Abubaker, Jehad
- Database ID:
- RPEP-07702
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07702APA
Al-Sabah, Salman; Al-Khairi, Irina; Jamal, Mohammad; Qaddoumi, Mohammad; Alajmi, Fahad; Kumar, Jijin; Abukhalaf, Nermeen; Cherian, Preethi; Madhu, Dhanya; Arefanian, Hossein; Dsouza, Carol; Alam-Eldin, Nada; AlSabagh, Abdullah; Al Madhoun, Ashraf; Al-Sabah, Suleiman; Al-Mulla, Fahd; Abu-Farha, Mohamed; Abubaker, Jehad. (2024). Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 33(5), 478-490. https://doi.org/10.1159/000540534
MLA
Al-Sabah, Salman, et al. "Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.." Medical principles and practice : international journal of the Kuwait University, 2024. https://doi.org/10.1159/000540534
RethinkPeptides
RethinkPeptides Research Database. "Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Ins..." RPEP-07702. Retrieved from https://rethinkpeptides.com/research/al-sabah-2024-effect-of-dual-glucagonlike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.